Can spit reveal how smoking fuels gum disease?

NCT ID NCT07764549

First seen Aug 14, 2026 · Last updated Aug 14, 2026

Summary

This study looks at whether smoking and advanced gum disease (Stage III periodontitis) are linked to changes in three saliva markers: TNF-α, FoxO-1, and SIRT-1, which are involved in inflammation and stress responses. Researchers will compare saliva samples from 80 adults divided into four groups: healthy non-smokers, non-smokers with gum disease, healthy smokers, and smokers with gum disease. The goal is to understand how smoking and gum disease together affect the body's inflammatory pathways, which could inform future prevention and treatment approaches.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Salivary biomarker analysis (ELISA) measuring TNF-α, FoxO-1, and SIRT-1 levels
What this could lead to
If links are found, saliva tests might one day help spot gum disease risk or guide prevention and treatment strategies.
What could go wrong
This is a small observational study, so it can't prove cause and effect. Results may not apply to everyone, and the markers might not be reliable indicators.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIODONTITIS (STAGE 3) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Cigarette Smoking Inflammation periodontitis Smoking

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • İstanbul Medipol University, Faculty of Dentistry, Department of Periodontology

    Istanbul, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.